Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy.

× No keyword cloud information.

6 in total

Review 1. Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.

Authors: M Rossini; R Zanotti; G Orsolini; G Tripi; O Viapiana; L Idolazzi; A Zamò; P Bonadonna; V Kunnathully; S Adami; D Gatti
Journal: Osteoporos Int Date: 2016-02-18 Impact factor: 4.507

2. Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.

Authors: M Laroche; J Bret; A Brouchet; B Mazières
Journal: Clin Rheumatol Date: 2006-08-11 Impact factor: 2.980

Review 3. Mastocytosis: update on pharmacotherapy and future directions.

Authors: Juan Carlos Cardet; Cem Akin; Min Jung Lee
Journal: Expert Opin Pharmacother Date: 2013-10 Impact factor: 3.889

Review 4. Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review.

Authors: Ichraq Latar; Meriem Koufany; Julie Hablot; Damien Loeuille; Patrick Netter; Jean-Yves Jouzeau; Isabelle Chary-Valckenaere; David Moulin
Journal: Clin Rheumatol Date: 2016-08-09 Impact factor: 2.980

Review 5. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors: Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal: Br J Clin Pharmacol Date: 2018-12-25 Impact factor: 4.335

Review 6. Mast Cell Clonal Disorders: Classification, Diagnosis and Management.

Authors: Merel C Onnes; Luciana K Tanno; Joanne N G Oude Elberink
Journal: Curr Treat Options Allergy Date: 2016-11-08

6 in total